Lantern Pharma Funding & Investors
Lantern Pharma Inc. operates as a biotechnology company. The Company develops drugs for the treatment of cancer. Lantern Pharma serves cancer patients in the United States.
lanternpharma.comTotal Amount Raised: $94,980,000
Lantern Pharma Funding Rounds
Post Ipo Secondary
$60,000,000
Undisclosed
$26,250,000
Series Unknown
$3,200,000
Series A
$3,700,000
Series A Investors
GPG VenturesBios PartnersPre Seed
$30,000
Pre Seed Investors
Health WildcattersGrant
$800,000
Seed
$1,000,000
Seed Investors
Green Park & Golf Ventures
Funding info provided by Diffbot.